Holen Sie sich die Stockscreener-App
2.8326
1.22%
-0.0274
Schlusskurs vom Vortag:
$2.86
Offen:
$2.8568
24-Stunden-Volumen:
9,173
Relative Volume:
0.01
Marktkapitalisierung:
$20.55M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-3.5118
EPS:
-0.8066
Netto-Cashflow:
-
1W Leistung:
+19.20%
1M Leistung:
+19.20%
6M Leistung:
-6.46%
1J Leistung:
-9.46%
1-Tages-Spanne:
$2.8125
$2.8901
1-Wochen-Bereich:
$2.42
$2.92
52-Wochen-Spanne:
$1.33
$6.20
Neuraxis Inc Stock (NRXS) Company Profile
Firmenname
Neuraxis Inc
Sektor
Branche
Telefon
(812) 689-0791
Adresse
11550 North Meridian Street, Suite 325, Carmel
Vergleichen Sie NRXS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NRXS
Neuraxis Inc
|
2.8473 | 23.44M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
476.04 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.83 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.11 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.91 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.75 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Neuraxis Inc Aktie (NRXS) Neueste Nachrichten
Is NeurAxis Inc. a good long term investmentSky-high profits - jammulinksnews.com
What drives NeurAxis Inc. stock priceConsistent high-yield stocks - jammulinksnews.com
NeurAxis Inc. Stock Analysis and ForecastAccelerated profit realization - jammulinksnews.com
What analysts say about NeurAxis Inc. stockFast-track wealth growth - jammulinksnews.com
is neuraxis inc. stock a growth or value play2x 3x 5x Pick Alert - Newser
Why NeurAxis Inc. stock is on top investor watchlistsMinimized Risk Maximum Return - Newser
Is NeurAxis Inc. stock a growth or value playFree Signals Group - Newser
Published on: 2025-07-18 00:27:06 - Newser
How NeurAxis Inc. stock performs during market volatilityLow Risk Stock Strategies - Newser
Why NeurAxis Inc. stock attracts strong analyst attentionGrowth Optimized Stock Radar - Newser
What makes NeurAxis Inc. stock price move sharplySteady Profit Stock Forecasts - Newser
Thursday’s Insider Moves: Top Executives Make Strategic Trades - Investing.com Australia
Major Shareholder Sells Massive Stake in NeurAxis, Inc. - TipRanks
Neuraxis ends Masimo license agreement and launches employee stock plan - Investing.com
Neuraxis Inc: Brian Hannasch buys $800k in shares - Investing.com
Neuraxis Inc: Brian Hannasch buys $800k in shares By Investing.com - Investing.com Nigeria
The Zacks Analyst Blog Highlights Microsoft, NVIDIA, Bank of America, BK Technologies and NeurAxis - Yahoo Finance
Top Stock Reports for Microsoft, NVIDIA & Bank of America - TradingView
Neuraxis announces new medical policy with two health insurers - TipRanks
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives - GlobeNewswire
NeurAxis, Inc. Expands Insurance Coverage for IB-Stim Therapy, Enhancing Access for Patients with Abdominal Pain - Nasdaq
NeurAxis (NASDAQ:NRXS) Now Covered by Analysts at Craig Hallum - Defense World
Neuraxis (NRXS) Initiated with Buy Rating by Craig-Hallum | NRXS Stock News - GuruFocus
Craig-Hallum initiates NeurAxis stock with buy rating on pediatric device - Investing.com India
Craig-Hallum bullish on Neuraxis, initiates with a Buy - TipRanks
Neuraxis, Inc. Secures Key Academic Society Guidelines Recommendation for Treatment of Functional Abdominal Pain in Ibs - MarketScreener
NeurAxis (NRXS) Gains Momentum with Key Guideline Inclusion | NR - GuruFocus
Neuraxis secures key academic society guidelines recommendation for FAP - TipRanks
NeurAxis Achieves Critical Milestone; Secures Key Academic - GlobeNewswire
Major Medical Guidelines Back NeurAxis $3B IBS Treatment for Children, Only FDA-Cleared Option - Stock Titan
47,094 Shares in NeurAxis, Inc. (NASDAQ:NRXS) Bought by Citadel Advisors LLC - Defense World
Finanzdaten der Neuraxis Inc-Aktie (NRXS)
Es liegen keine Finanzdaten für Neuraxis Inc (NRXS) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
4.11%
0.52%
Kapitalisierung:
|
Volumen (24h):